# Takeda Pharamaceutical Company Limited – FDA Inspection, Jun 6, 2025

Source: https://www.keypedia.com/records/fda_inspections/takeda-pharamaceutical-company-limited/d7a387ed-5276-41d8-894f-77bea6156cd4
Source feed: FDA_Inspections

> FDA inspection 1274303 of Takeda Pharamaceutical Company Limited, June 06, 2025. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1274303
- Company Name: Takeda Pharamaceutical Company Limited
- Inspection Date: 2025-06-06
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Denver District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1099094 - 2019-07-17
- FDA Inspection 1050331 - 2018-04-10

## Related Officers

- [Investigator](https://www.keypedia.com/people/david-a-moore/361e4fe8-caf0-4320-963a-3838616850e2)

Company: https://www.keypedia.com/companies/takeda-pharamaceutical-company-limited/dd8ea3d2-c1ad-4e50-aadb-1c84da3652fd

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face